LUVCELEBS
Daily meet celebrity with new activity
HOME
TOP KEYWORDS
SAXENDA
LEADER: LLIRAGLUTIDE AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES ( AND USE IN OBESITY)
Follow @luvCelebs
LEADER: Lliraglutide and cardiovascular outcomes in type 2 diabetes ( and use in obesity)
Comments
Please enable JavaScript to view the
comments powered by Disqus.
comments powered by
Disqus